Cas no 92-54-6 (1-Phenylpiperazine)
1-Phenylpiperazine Chemical and Physical Properties
Names and Identifiers
-
- 1-Phenylpiperazine
- N-Phenylpiperazine
- 1-Fenylpiperazin
- 1-fenylpiperazine
- 1-PHENYLPIPERAINE
- 1-phenyl-piperazine
- 4-Phenylpiperazine
- 4-Ph-piperazine
- Phenylpiperazine
- Piperazine, 1-phenyl-
- 1-Fenylpiperazin [Czech]
- n-phenyl piperazine
- 1-phenyl piperazine
- J9225CBI7D
- YZTJYBJCZXZGCT-UHFFFAOYSA-N
- N-phenylpiperazin
- N-Phenyldiethylenediamine
- 1-phenylpiperazinehydrochloride
- phenyl-piperazine
- phenyl piperazine
- N-phenylpyperazine
- N-phenylpi
- N-phenyl piperazin
- DTXCID9031644
- AM81359
- AI3-26332
- MFCD00005957
- BCP22010
- CAS-92-54-6
- A4752
- VU9
- AC-2107
- N-phenylpiperizine
- 1-Phenylpiperazine, 99%
- BRN 0132157
- CCRIS 4334
- CHEMBL9434
- EINECS 202-165-6
- BDBM50001898
- DTXSID8057855
- AKOS000119106
- BB 0295926
- LF-0549
- NS00004455
- 4-phenylpiperizine
- P0980
- Piperazine, 1-phenyl-, dihydrochloride
- N'-phenyl-piperazine
- BIDD:GT0830
- Levodropropizine impurity B, European Pharmacopoeia (EP) Reference Standard
- UNII-J9225CBI7D
- CS-W019986
- NCGC00253765-01
- Q4862383
- SCHEMBL24889
- 1-Phenypiperazine
- 5-23-01-00160 (Beilstein Handbook Reference)
- AE-641/30105013
- SR-01000944921-1
- SR-01000944921
- 4-phenyl-piperazine
- InChI=1/C10H14N2/c1-2-4-10(5-3-1)12-8-6-11-7-9-12/h1-5,11H,6-9H
- 4-phenylpiperazin
- 92-54-6
- 1-N-phenylpiperazine
- F2190-0343
- EC 202-165-6
- 4-phenyl piperazine
- Tox21_113878
- PHENYLPIPERAZINE, 1-
- LEVODROPROPIZINE IMPURITY B [EP IMPURITY]
- Q-100891
- FT-0631450
- N-phenyl-piperazine
- AB00546
- 1-Phenylpiperazine, 97%
- BBL027548
- 1-Phenylpiperazine; N-Phenylpiperazine; NPP; Phenylpiperazine; Levodropropizine Imp. B (EP)
- STL282711
- LEVODROPROPIZINE IMPURITY B (EP IMPURITY)
- DB-027446
- FP10343
-
- MDL: MFCD00005957
- Inchi: 1S/C10H14N2/c1-2-4-10(5-3-1)12-8-6-11-7-9-12/h1-5,11H,6-9H2
- InChI Key: YZTJYBJCZXZGCT-UHFFFAOYSA-N
- SMILES: N1(C2C=CC=CC=2)CCNCC1
- BRN: 0132157
Computed Properties
- Exact Mass: 162.11600
- Monoisotopic Mass: 162.116
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 12
- Rotatable Bond Count: 1
- Complexity: 124
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.1
- Topological Polar Surface Area: 15.3
- Surface Charge: 0
- Tautomer Count: nothing
Experimental Properties
- Color/Form: Not determined
- Density: 1.062?g/mL?at 25?°C(lit.)
- Melting Point: 18.8 oC
- Boiling Point: 286?°C(lit.)
- Flash Point: Fahrenheit: 284 ° f
Celsius: 140 ° c - Refractive Index: n20/D 1.588(lit.)
- Solubility: Insoluble
- Water Partition Coefficient: Insoluble
- PSA: 15.27000
- LogP: 1.49000
- FEMA: 2699
- Solubility: Not determined
- Sensitiveness: Sensitive to air
1-Phenylpiperazine Security Information
-
Symbol:
- Prompt:dangerous
- Signal Word:Danger
- Hazard Statement: H301,H311,H314
- Warning Statement: P280,P305+P351+P338,P310
- Hazardous Material transportation number:UN 2922 8/PG 2
- WGK Germany:3
- Hazard Category Code: 22-24-34
- Safety Instruction: S26-S36/37/39-S45-S28A
- RTECS:TM2625000
-
Hazardous Material Identification:
- HazardClass:8 (6.1)
- PackingGroup:III
- TSCA:Yes
- Storage Condition:Store at room temperature
- Safety Term:6.1
- Packing Group:II
- Risk Phrases:R22; R24; R34
1-Phenylpiperazine Customs Data
- HS CODE:29335995
- Customs Data:
China Customs Code:
2933599090Overview:
2933599090. Other compounds with pyrimidine ring in structure(Including other compounds with piperazine ring on the structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
1-Phenylpiperazine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 021544-5g |
1-Phenylpiperazine |
92-54-6 | 98% | 5g |
£10.00 | 2022-03-01 | |
| Fluorochem | 021544-25g |
1-Phenylpiperazine |
92-54-6 | 98% | 25g |
£15.00 | 2022-03-01 | |
| Fluorochem | 021544-100g |
1-Phenylpiperazine |
92-54-6 | 98% | 100g |
£25.00 | 2022-03-01 | |
| Alichem | A139002890-500g |
1-Phenylpiperazine |
92-54-6 | 97% | 500g |
$359.00 | 2023-08-31 | |
| YAN FENG KE JI ( BEI JING ) Co., Ltd. | H22483-25g |
1-Phenylpiperazine |
92-54-6 | 97% | 25g |
¥64 | 2023-09-19 | |
| YAN FENG KE JI ( BEI JING ) Co., Ltd. | H22483-100g |
1-Phenylpiperazine |
92-54-6 | 97% | 100g |
¥156 | 2023-09-19 | |
| YAN FENG KE JI ( BEI JING ) Co., Ltd. | H22483-500g |
1-Phenylpiperazine |
92-54-6 | 97% | 500g |
¥505 | 2023-09-19 | |
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | P0980-250G |
1-Phenylpiperazine |
92-54-6 | >98.0%(GC) | 250G |
¥3,510.00 | 2021-05-19 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R002172-100g |
1-Phenylpiperazine |
92-54-6 | 97% | 100g |
¥105 | 2024-05-20 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R002172-25g |
1-Phenylpiperazine |
92-54-6 | 97% | 25g |
¥28 | 2024-05-20 |
1-Phenylpiperazine Suppliers
1-Phenylpiperazine Related Literature
-
1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
-
Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
-
Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
-
Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
Additional information on 1-Phenylpiperazine
Chemical Profile of 1-Phenylpiperazine (CAS No. 92-54-6)
1-Phenylpiperazine (CAS No. 92-54-6) is a significant compound in the field of organic chemistry and pharmaceutical research, characterized by its piperazine ring substituted with a phenyl group. This structural motif has garnered considerable attention due to its diverse pharmacological properties and potential applications in medicinal chemistry. The compound belongs to the class of phenylpiperazine derivatives, which are widely studied for their involvement in various biological and chemical processes.
The molecular structure of 1-Phenylpiperazine consists of a six-membered aromatic ring attached to a six-membered piperazine ring. This configuration imparts unique electronic and steric properties to the molecule, making it a versatile scaffold for drug design. The presence of the phenyl group enhances the lipophilicity of the compound, facilitating its interaction with biological targets such as receptors and enzymes. This feature has been exploited in the development of novel therapeutic agents targeting neurological and cardiovascular disorders.
In recent years, 1-Phenylpiperazine has been extensively researched for its potential role in central nervous system (CNS) pharmacology. Studies have demonstrated its ability to modulate neurotransmitter systems, particularly those involving serotonin and dopamine. The compound's affinity for certain serotonin receptors has led to investigations into its potential as an antidepressant or anxiolytic agent. However, research also highlights its complex pharmacokinetic profile, which includes rapid metabolism and potential for active metabolites, necessitating careful consideration in drug development.
Moreover, the derivatives of 1-Phenylpiperazine have been explored in the context of neurodegenerative diseases. Emerging research suggests that modifications to the phenyl or piperazine rings can significantly alter the biological activity of the molecule. For instance, certain analogs have shown promise in preclinical studies as potential treatments for conditions such as Parkinson's disease and Alzheimer's disease. These findings underscore the importance of 1-Phenylpiperazine as a key intermediate in the synthesis of novel therapeutics targeting CNS disorders.
The synthesis of 1-Phenylpiperazine typically involves classical organic reactions such as reductive amination or nucleophilic substitution on an appropriately substituted piperazine precursor. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to conduct large-scale studies and industrial applications. The compound's stability under various conditions further enhances its utility in pharmaceutical manufacturing and research settings.
From a chemical biology perspective, 1-Phenylpiperazine serves as a valuable tool for understanding receptor-ligand interactions. Its structural similarity to natural neuromodulators allows researchers to probe the mechanisms underlying neurotransmitter function. High-throughput screening campaigns have identified several derivatives with enhanced binding affinity or selectivity for specific receptors, paving the way for next-generation pharmacological agents.
The industrial relevance of 1-Phenylpiperazine extends beyond pharmaceuticals into agrochemicals and specialty chemicals. Its derivatives exhibit properties that make them suitable for use as intermediates in the synthesis of dyes, polymers, and other fine chemicals. The compound's versatility underscores its importance as a building block in synthetic chemistry.
In conclusion, 1-Phenylpiperazine (CAS No. 92-54-6) is a multifaceted compound with significant implications in pharmaceutical research and industrial applications. Its unique structural features enable diverse biological activities, making it a cornerstone in drug discovery efforts targeting neurological and other disorders. Continued exploration into its derivatives and synthetic pathways promises to yield novel compounds with enhanced therapeutic potential.
92-54-6 (1-Phenylpiperazine) Related Products
- 115619-01-7(4-(4-Ethylpiperazin-1-yl)aniline)
- 16153-81-4(4-(4-methylpiperazin-1-yl)aniline)
- 7479-12-1(4-[4-(4-aminophenyl)piperazin-1-yl]aniline)
- 21091-61-2(2-(4-phenylpiperazin-1-yl)ethan-1-amine)
- 67455-41-8(1-(4-Aminophenyl)piperazine)
- 3074-43-9(1-Methyl-4-phenylpiperazine)
- 91703-23-0(N,N-dimethyl-4-(piperazin-1-yl)aniline)
- 114-28-3(Piperazinium,1,1-dimethyl-4-phenyl-)
- 57498-25-6(1-Ethyl-4-phenylpiperazine)
- 613-39-8(1,4-Diphenylpiperazine)